TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/4/18 16:57 | 4/2/18 | AVXS | Avexis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Knudten Andrew F. | IL | O | SrVP,Man | S.d | -239 | 119.49 | 0 | -2 | -19 | 9 | D | ||||||||||||||
3/5/18 16:38 | 3/1/18 | AVXS | Avexis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Knudten Andrew F. | IL | O | SrVP,Man | S.d | -252 | 126.12 | 0 | -2 | -29 | 5 | D | ||||||||||||||
2/5/18 16:56 | 2/1/18 | AVXS | Avexis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Knudten Andrew F. | IL | O | SrVP,Man | S.d | -236 | 118.13 | 0 | -2 | -29 | 5 | D | ||||||||||||||
1/4/18 17:39 | 1/2/18 | AVXS | Avexis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Knudten Andrew F. | IL | O | SrVP,Man | S.d | -219 | 109.71 | 0 | -2 | -29 | 5 | D | ||||||||||||||
12/5/17 18:36 | 12/4/17 | AVXS | Avexis, Inc. | DE | Health | BioPrd | Biological Products, (No Diag | Knudten Andrew F. | IL | O | SrVP,Man | S.d | -189 | 94.48 | 0 | -2 | -29 | 5 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |